The Extended Use of Eculizumab in Pregnancy and Complement Activation-Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now?

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

Originalspråkengelska
Artikelnummer407
TidskriftJournal of clinical medicine
Volym8
Utgåva3
Antal sidor20
ISSN2077-0383
DOI
StatusPublicerad - 24 mar 2019
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

  • 3123 Kvinno- och barnsjukdomar

Citera det här

@article{00ff26aa891d44c78140447cc635c95a,
title = "The Extended Use of Eculizumab in Pregnancy and Complement Activation-Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now?",
keywords = "eculizumab, pregnancy, premature birth, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, antiphospholipid syndrome, sickle-cell anemia, HELLP, fetal kidney development, complement activation, HEMOLYTIC-UREMIC SYNDROME, SICKLE-CELL-DISEASE, PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, ELEVATED LIVER-ENZYMES, PERINATAL OUTCOMES, HELLP-SYNDROME, INHIBITOR ECULIZUMAB, ADULT PATIENTS, UNITED-STATES, FOLLOW-UP, 3123 Gynaecology and paediatrics",
author = "Vedran Stefanovic",
year = "2019",
month = "3",
day = "24",
doi = "10.3390/jcm8030407",
language = "English",
volume = "8",
journal = "Journal of clinical medicine",
issn = "2077-0383",
publisher = "MDPI",
number = "3",

}

TY - JOUR

T1 - The Extended Use of Eculizumab in Pregnancy and Complement Activation-Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now?

AU - Stefanovic, Vedran

PY - 2019/3/24

Y1 - 2019/3/24

KW - eculizumab

KW - pregnancy

KW - premature birth

KW - paroxysmal nocturnal hemoglobinuria

KW - atypical hemolytic uremic syndrome

KW - antiphospholipid syndrome

KW - sickle-cell anemia

KW - HELLP

KW - fetal kidney development

KW - complement activation

KW - HEMOLYTIC-UREMIC SYNDROME

KW - SICKLE-CELL-DISEASE

KW - PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA

KW - ELEVATED LIVER-ENZYMES

KW - PERINATAL OUTCOMES

KW - HELLP-SYNDROME

KW - INHIBITOR ECULIZUMAB

KW - ADULT PATIENTS

KW - UNITED-STATES

KW - FOLLOW-UP

KW - 3123 Gynaecology and paediatrics

U2 - 10.3390/jcm8030407

DO - 10.3390/jcm8030407

M3 - Review Article

VL - 8

JO - Journal of clinical medicine

JF - Journal of clinical medicine

SN - 2077-0383

IS - 3

M1 - 407

ER -